Abstract
Objective-To evaluate the effect of permanent pacing in cardioinhibitory malignant vasovagal syndrome. Patients and methods-37 patients with permanent pacemakers for cardioinhibitory malignant vasovagal syndrome. All presented with syncope (median six episodes, median frequency two episodes a year) and after conventional investigation and invasive electrophysiological assessment they remained undiagnosed, and without a generally accepted indication for pacemaker implantation. In all vasovagal syncope with cardioinhibition (heart rate at syncope <60 beats/min) developed during tilt tests performed according to the Westminster protocol (head up tilt at 600 with a footplate support for 45 minutes or until syncope intervenes). Dual chamber pacemakers were implanted in 35 (95%) and VVI pacemakers in the remaining two (5%). Results-Over a mean (SD) follow up since implantation of 50-2 (23-9) months symptomatic improvement occurred in 890/%: 62% remained free of syncope and 27% were completely symptom free. The collective syncopal burden of these 37 patients was reduced from 136 to 11 episodes each year. During follow up three patients died from unrelated causes. Patients who become asystolic during the tilt test (sinus pause of at least four seconds) experienced no greater benefit from pacing than those with less extreme cardioinhibition. Patients who remained free of syncope since implantation were younger than those who continued to experience syncope. Patients who remained completely symptom free after implantation were younger, more likely to be male, and had had fewer syncopal episodes before implantation than those who continued to Recurrent syncope is a common clinical problem which, despite extensive investigation, remains unexplained in 30%-50% of patients.'-In 1986 Kenny et al reported a series of 15 patients with unexplained syncope who had been subjected to prolonged head up tilt at 400 for up to 60 minutes.5 Ten (67%) of this group developed vasovagal syncope during tilt by contrast with one (10%) of 10 age matched controls. The authors suggested that vasovagal syncope was the cause of these patients' clinical events and that a prolonged head up tilt test was a useful test in the investigation of unexplained syncope. Subsequently, tilt testing in this context has been widely evaluated, the original findings reproduced,46-9 and the conclusions of Kenny et al are now generally accepted.4~"
The nature of the predisposition to vasovagal syncope identified by tilt tests may vary between subjects and has been incompletely established. 12-14 Therefore, at present, patients with otherwise unexplained syncope and positive tilt tests are best considered clinically as having malignant vasovagal syndrome.'516
The term malignant has been included to indicate that the presentation is of frequent or severe syncopal attacks that may be clinically difficult to distinguish from Adams-Stokes
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PACEMAKER MODE AND PROGRAMMING SELECTIONS
Dual chamber pacing had been selected for all but two patients (one with atrial fibrillation) to achieve maximum haemodynamic benefit during support of bradycardia, and minimise the occurrence of pacemaker syndrome. Most patients (84%) had been initially paced in DDI mode with rate hysteresis. The DDI mode excludes the possibility of pacemaker mediated tachycardia. Rate hysteresis with a trigger rate selected below the subjects sleeping heart rate avoids unnecessary pacing under normal circumstances and allows a higher rate of pacing support when required.
COLLECTION OF DATA
For all patients complete records of demographic details, symptoms before *Tilt performed for 60 minutes before change in method. Tilts total number of tilt tests before implantation; P, positive; N, negative; Time, time of positive tilt; HRs, resting heart rate; HRmax, maximum heart rate; HRe, minimum heart rate at syncope; BPSYSs, resting systolic blood pressure; BPDIAs, resting diastolic blood pressure. bundle branch block 3%, atrial fibrillation 3%, and a non-specific repolarisation abnormality 3%). Table 1 shows the clinical characteristics and 12 lead resting electrocardiographic findings before implantation.
RESULTS OF TILT TEST
A total of 60 tilt tests were performed before implantation, 78% of which were positive. The first tilt was positive in 86% of patients, and 100% were positive after three tilt tests. Discordant outcomes of tilt tests were present in 22% of patients. The mean time to syncope in the positive tilt tests was 22-5 (SD 13-3, median 21, range 1-55) minutes. The mean heart rate at syncope was 305 (SD 18 1, median 33, range 1-59) beats/min and 30% of patients developed asystole (sinus pause of at least four seconds) during one or more tilts. -A younger age at implantation, male sex, and fewer episodes of syncope before implantation were found in the group who had remained free of symptoms after pacing, compared with the group that had continued to experience symptoms. Only a younger age, however, was found in the group that remained free of syncope compared with the group that had not. There was no difference in investigations or tilt test results before implantation, including asystole, between the 'T outcome groups. There were no differences in the pacing mode at implantation, or in programming between the outcome groups. Tables 4-6 show subgroup data with statistical analysis.
Discussion
The 37 patients included in this study had no conventional indication for permanent pacing. Clinical evaluation, conventional investigation, and invasive electrophysiological tests had failed to explain their syncope. On the basis of these negative findings, the severity of their presentation and positive cardioinhibitory vasovagal syncope during tilt tests, they were classified as having cardioinhibitory malignant vasovagal syndrome and received permanent pacemakers. Over a mean follow up of more than-4 years none has shown an alternative reason for syncope and collectively the patients have experienced a considerable reduction in the frequency of syncope and symptoms.
The age and sex distributions of these patients were similar to those of all patients tilted for unexplained syncope in our unit over the same period (366 patients, mean (SD) age 61-6 (17-6) years, 56% men), and was similar to the tilt positive patients in the series of Raviele et al (mean (SD) age 60 (16) years, 67% men), in which the investigations before tilt testing and tilt test method were similar to our own.9 When compared with patients defined as having tilt positive cardioinhibitory vasovagal syndrome in series using different selection criteria and tilt methods, our patients are somewhat older.
" 22 Despite this difference these patients are probably typical of a syndrome that represents an important proportion of all patients presenting with unexplained syncope.45 9 In 95% of our patients dual chamber pacing was used in an attempt to maximise haemodynamic benefit during pacing, and Subgroup analysis of the data was undertaken in an attempt to identify characteristics before implantation or pacing variables that predicted a more favourable outcome. Apart from the younger age at implantation in patients who remained free of syncope, no other important differences were identified.
THE ROLE OF TILT TESTS IN PATIENT SELECTION
The use of prolonged head up tilt tests in the diagnostic evaluation of unexplained syncope to identify patients with a predisposition to vasovagal syncope has become increasingly accepted.46-21416182022 Furthermore the test provides a haemodynamic profile of the vasovagal decompensation that allows two broad groups of patients to be separated, those with significant bradycardia as well as hypotension at syncope, cardioinhibitory vasovagal syncope-the classical vasovagal syncope described by Lewis27-and those with predominant hypotension, vasodepressor vasovagal syncope.5620 This distinction lacks both an aetiological explanation and a precise definition, but may be important in the choice of treatment.56920
On the basis of the outcome of the tilt test we implanted pacemakers in patients who developed any degree of bradycardia rather than restrict pacing to patients with the most severe cardioinhibition or asystole as have other centres.9 15 18 Interestingly, retrospective analysis of our patients does not suggest a greater impact of pacing treatment on those with tilt induced asystole compared with those who developed lesser degrees of bradycardia. It is possible that whereas tilt testing enables recognition of subjects with vasovagal syncope, the nature of the artificial tilt induced episodes are poor reflections of the clinical vasovagal episodes. Another interpretation of this finding is that the absolute level of cardioinhibition is less important, with respect to pacing efficacy, than the rate of development of bradycardia and its temporal relation to the fall in blood pressure. We have modified our method of tilt test to obtain continuous heart rate and non-invasive blood pressure data, thus enabling a more detailed classification of the events occurring during syncope.28 It is possible that this improved method will allow better selection of patients for pacing (fig 1) . hydrochloride, hyoscine, dihydroergotamine, domperidone, and cafedrine) have been reported.9 18293941 These studies used tilt tests after giving drugs to identify suitable agents for longer term treatment. Recurrent syncope occurred in 0%-20% of treated patients over a variable follow up (mean 10-7-21 months). Differences in the selection of patients, methods of tilt test, definitions of positive outcomes, and duration of follow up makes meaningful comparison of these studies with our own impossible. In the only placebo controlled study of medical treatment there was no difference in rate of recurrence of syncope between the two groups.39 STUDY 
LIMITATIONS
This study is retrospective and uncontrolled. Comparison of rates of syncope before and after pacemaker implantation provides apparently powerful evidence to suggest a massive reduction in the predicted collective syncopal burden of the study group. This interpretation of the results of this study should be treated with caution as patients presenting for investigation of syncope may overestimate their previous symptoms, and rates of syncope in patients with unexplained syncope after investigation are lower than expected irrespective of treatment.
In conclusion any treatment for cardioinhibitory malignant vasovagal syndrome must be regarded as provisional and untested. The efficacy of various treatments remains unproved. This study presents an unconventional treatment strategy in a well defined patient group and suggests a possible role for permanent pacing. Pacing should be evaluated more formally in a prospective controlled randomised study.
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